Article
Chronic lymphocytic leukaemia.
Lancet (London, England) - 14 Apr 2018
Hallek Michael, Shanafelt Tait D, Eichhorst Barbara
Abstract excerpt
Important advances in understanding the pathogenesis of chronic lymphocytic leukaemia in the past two decades have led to the development of new prognostic tools and novel targeted therapies that have improved clinical outcome. Chronic lymphocytic leukaemia is the most common type of leukaemia in developed countries, and the median age at diagnosis is 72 years. The criteria for initiating treatment rely on the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.